tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Gil Blum, 416 are a BUY (97.2%), 9 are a HOLD (2.1%), 3 are a SELL (0.7%).
Analyst Gil Blum, currently employed at NEEDHAM, carries an average stock price target met ratio of 26.95% that have a potential upside of 60.65% achieved within 149 days. Previously, Gil Blum worked at TRUIST.
Gil Blum’s has documented 799 price targets and ratings displayed on 30 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on SLDB, Solid Biosciences LLC at 20-Mar-2026.
Analyst best performing recommendations are on CTIC (CTI BIOPHARMA CORP).
The best stock recommendation documented was for CELC (CELCUITY LLC) at 6/30/2025. The price target of $29 was fulfilled within 28 days with a profit of $15.65 (117.23%) receiving and performance score of 41.87.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 06-Jan-2022
$2
$0.6 (42.86%)
2 years 3 months 6 days ago
(18-Dec-2023)
0/2 (0%)
$0.7 (53.85%)
Buy Since 04-May-2021
$2
$0.6 (42.86%)
$36
2 years 8 months 11 days ago
(13-Jul-2023)
0/2 (0%)
$0.59 (41.84%)
Hold Since 12-Jul-2023
$2
$0.6 (42.86%)
$2
2 years 8 months 12 days ago
(12-Jul-2023)
1/3 (33.33%)
$0.57 (39.86%)
7
Buy Since 07-Dec-2022
3 years 3 months 17 days ago
(07-Dec-2022)
0/2 (0%)
$13.44 (140.59%)
Buy Since 27-May-2021
3 years 10 months 7 days ago
(17-May-2022)
0/1 (0%)
$19.05 (212.85%)
Which stock is Gil Blum is most bullish on?
Which stock is Gil Blum is most reserved on?
What Year was the first public recommendation made by Gil Blum?
